Northwest Bio enters USD 4.9 million convertible note financing with Yorkville Advisors fund
NWBO•Conversion and warrant terms
The note is convertible at the holder’s option at a small discount to the prevailing market price.
Yorkville also received a warrant to buy up to USD 2 million of shares at USD 0.21 per share.
Standby equity subscription agreement
A standby equity subscription agreement allows up to USD 50 million of share purchases over 24 months once the note is repaid or converted.
Convertible note financing with Yorkville-managed fund
Northwest Biotherapeutics entered a USD 4.9 million convertible promissory note financing with YA II PN, a Yorkville-managed fund, on July 29, 2026.
The note has a 12-month term, with no payments due until maturity. It carries a 5% original issue discount and no interest.
